Literature DB >> 25702155

Tumor suppressive functions of ceramide: evidence and mechanisms.

Sehamuddin Galadari1, Anees Rahman, Siraj Pallichankandy, Faisal Thayyullathil.   

Abstract

Studies over the past two decades have identified ceramide as a multifunctional central molecule in the sphingolipid biosynthetic pathway. Given its diverse tumor suppressive activities, molecular understanding of ceramide action will produce fundamental insights into processes that limit tumorigenesis and may identify key molecular targets for therapeutic intervention. Ceramide can be activated by a diverse array of stresses such as heat shock, genotoxic damage, oxidative stress and anticancer drugs. Ceramide triggers a variety of tumor suppressive and anti-proliferative cellular programs such as apoptosis, autophagy, senescence, and necroptosis by activating or repressing key effector molecules. Defects in ceramide generation and metabolism in cancer contribute to tumor cell survival and resistance to chemotherapy. The potent and versatile anticancer activity profile of ceramide has motivated drug development efforts to (re-)activate ceramide in established tumors. This review focuses on our current understanding of the tumor suppressive functions of ceramide and highlights the potential downstream targets of ceramide which are involved in its tumor suppressive action.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25702155     DOI: 10.1007/s10495-015-1109-1

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  34 in total

1.  Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells.

Authors:  Li-Pin Kao; Samy A F Morad; Traci S Davis; Matthew R MacDougall; Miki Kassai; Noha Abdelmageed; Todd E Fox; Mark Kester; Thomas P Loughran; Jose' L Abad; Gemma Fabrias; Su-Fern Tan; David J Feith; David F Claxton; Sarah Spiegel; Kelsey H Fisher-Wellman; Myles C Cabot
Journal:  J Lipid Res       Date:  2019-07-30       Impact factor: 5.922

Review 2.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

Review 3.  Sphingolipids and their metabolism in physiology and disease.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-22       Impact factor: 94.444

4.  Effect of inhibiting Beclin-1 expression on autophagy, proliferation and apoptosis in colorectal cancer.

Authors:  Lin Liu; Wei-Min Zhao; Xin-Hui Yang; Zhen-Qiang Sun; Hui-Zhen Jin; Cheng Lei; Bo Jin; Hai-Jiang Wang
Journal:  Oncol Lett       Date:  2017-07-28       Impact factor: 2.967

5.  Overexpression of acid ceramidase (ASAH1) protects retinal cells (ARPE19) from oxidative stress.

Authors:  Eriko Sugano; Genea Edwards; Saikat Saha; Lynda A Wilmott; Richard C Grambergs; Koushik Mondal; Hui Qi; Megan Stiles; Hiroshi Tomita; Nawajes Mandal
Journal:  J Lipid Res       Date:  2018-11-09       Impact factor: 5.922

6.  Proteome-wide Identification of Novel Ceramide-binding Proteins by Yeast Surface cDNA Display and Deep Sequencing.

Authors:  Scott Bidlingmaier; Kevin Ha; Nam-Kyung Lee; Yang Su; Bin Liu
Journal:  Mol Cell Proteomics       Date:  2016-01-04       Impact factor: 5.911

7.  An Altered Sphingolipid Profile as a Risk Factor for Progressive Neurodegeneration in Long-Chain 3-Hydroxyacyl-CoA Deficiency (LCHADD).

Authors:  Sara Tucci
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

8.  Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia.

Authors:  Samy A F Morad; Traci S Davis; Mark Kester; Thomas P Loughran; Myles C Cabot
Journal:  Leuk Res       Date:  2015-07-02       Impact factor: 3.156

9.  A search for ceramide binding proteins using bifunctional lipid analogs yields CERT-related protein StarD7.

Authors:  Svenja Bockelmann; John G M Mina; Sergei Korneev; Dina G Hassan; Dagmar Müller; Angelika Hilderink; Hedwich C Vlieg; Reinout Raijmakers; Albert J R Heck; Per Haberkant; Joost C M Holthuis
Journal:  J Lipid Res       Date:  2018-01-17       Impact factor: 5.922

10.  Novel glucosylceramide synthase inhibitor based prodrug copolymer micelles for delivery of anticancer agents.

Authors:  Jieni Xu; Whenchen Zhao; Jingjing Sun; Yixian Huang; Pengcheng Wang; Raman Venkataramanan; Da Yang; Xiaochao Ma; Ajay Rana; Song Li
Journal:  J Control Release       Date:  2018-09-14       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.